Found: 29
Select item for more details and to access through your institution.
Does the Germline Genome Encode for the Invasiveness of a Cutaneous Melanoma?
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1–Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 10, p. 1112, doi. 10.1001/jamadermatol.2023.2621
- By:
- Publication type:
- Article
The genetics of uveal melanoma: current insights.
- Published in:
- Application of Clinical Genetics, 2016, v. 9, p. 147
- By:
- Publication type:
- Article
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25332-w
- By:
- Publication type:
- Article
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1599, doi. 10.1007/s00262-009-0669-8
- By:
- Publication type:
- Article
Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 6, p. 1, doi. 10.1093/jncics/pkac074
- By:
- Publication type:
- Article
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.
- Published in:
- Human Genetics, 2016, v. 135, n. 11, p. 1241, doi. 10.1007/s00439-016-1715-1
- By:
- Publication type:
- Article
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study).
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1040, doi. 10.3390/cancers14041040
- By:
- Publication type:
- Article
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2440, doi. 10.3390/cancers13102440
- By:
- Publication type:
- Article
RAD51 can inhibit PDGF-B–induced gliomagenesis and genomic instability.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 12, p. 1277, doi. 10.1093/neuonc/nor131
- By:
- Publication type:
- Article
Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation.
- Published in:
- Nature Communications, 2016, v. 7, n. 10, p. 13241, doi. 10.1038/ncomms13241
- By:
- Publication type:
- Article
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00202
- By:
- Publication type:
- Article
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 9, p. 2220, doi. 10.1002/ijc.29595
- By:
- Publication type:
- Article
Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. 284, doi. 10.1111/jdv.18589
- By:
- Publication type:
- Article
The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility.
- Published in:
- Genes, Chromosomes & Cancer, 2016, v. 55, n. 7, p. 601, doi. 10.1002/gcc.22363
- By:
- Publication type:
- Article
Hereditary uveal melanoma: A report of a germline mutation in BAP1.
- Published in:
- Genes, Chromosomes & Cancer, 2013, v. 52, n. 4, p. 378, doi. 10.1002/gcc.22035
- By:
- Publication type:
- Article
Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 12, p. 1921, doi. 10.1080/0284186X.2023.2280766
- By:
- Publication type:
- Article
Familial features affecting the melanoma risk in CDKN2A-negative melanoma families: a study based on the Swedish Cancer Registry.
- Published in:
- 2023
- By:
- Publication type:
- Letter
BAP1 genetic testing among melanoma and cancer-prone families in Sweden.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 6, p. 565, doi. 10.1080/0284186X.2023.2216338
- By:
- Publication type:
- Article
Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy.
- Published in:
- 2022
- By:
- Publication type:
- Letter
CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015–2020: implications for novel national recommendations.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 7, p. 888, doi. 10.1080/0284186X.2021.1914346
- By:
- Publication type:
- Article
Surgery of metastatic melanoma after systemic therapy – the SUMMIST trial: study protocol for a randomized controlled trial.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 1, p. 52, doi. 10.1080/0284186X.2020.1846213
- By:
- Publication type:
- Article
Survival of the fittest or best adapted: HLA-dependent tumor development.
- Published in:
- Journal of Nucleic Acids Investigation, 2010, v. 1, n. 1-9, p. 41, doi. 10.4081/jnai.2010.1654
- By:
- Publication type:
- Article
Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1077, doi. 10.1093/jnci/djad081
- By:
- Publication type:
- Article
Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases.
- Published in:
- 2016
- By:
- Publication type:
- journal article